Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis
Hale, Martin, MD, Tudor, Iulia Cristina, PhD, Khanna, Sarita, PhD, Thipphawong, John, MD
Published in Clinical therapeutics (01.05.2007)
Published in Clinical therapeutics (01.05.2007)
Get full text
Journal Article
Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain
Wallace, Mark, Moulin, Dwight E, Rauck, Richard L, Khanna, Sarita, Tudor, Iulia Cristina, Skowronski, Roman, Thipphawong, John
Published in Journal of opioid management (01.03.2009)
Published in Journal of opioid management (01.03.2009)
Get more information
Journal Article